55 related articles for article (PubMed ID: 31513804)
1. Incidence and survival rates of primary cutaneous malignancies in Korea, 1999-2019: A nationwide population-based study.
Kwon SH; Choi S; Kim JS; Kim SS; Jue MS; Seo SH; Park J; Roh MR; Mun JH; Kim JY; Choi JW; Byun JW; Park S; Kim MS; Lee SJ;
J Dermatol; 2024 Apr; 51(4):532-538. PubMed ID: 38366757
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the tissue and serum levels of IL-35 in Mycosis fungoides: a case-control study.
Elmasry MF; Obaid YA; El-Samanoudy SI; Nour ZA; Doss SS
Arch Dermatol Res; 2024 Jun; 316(7):349. PubMed ID: 38850434
[TBL] [Abstract][Full Text] [Related]
3. Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane-based regimens.
Koizumi S; Doi R; Aitake U; Lei X; Izumi T; Mori T; Shojiguchi N; Kawasaki T; Inozume T; Kishi A
J Dermatol; 2024 Jun; 51(6):e203-e204. PubMed ID: 38216840
[No Abstract] [Full Text] [Related]
4. Mutational landscape of advanced extramammary Paget disease with comprehensive genomic profiling tests: A cohort study in a Japanese real-world setting.
Iwasawa O; Miyagawa T; Omatsu J; Matsuda KM; Awaji K; Yamada D; Kage H; Oda K; Sato S
J Am Acad Dermatol; 2024 Apr; 90(4):842-845. PubMed ID: 38072126
[No Abstract] [Full Text] [Related]
5. The elusive extremities: a case of extramammary Paget disease.
Radhakrishnan S; Sreeram S; Nayak K; Reddy SG
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38191219
[TBL] [Abstract][Full Text] [Related]
6. Oncological aspects related to non-surgical treatment of basal cell carcinoma. Comments on: chemotherapeutical treatment of basal cell carcinoma with bleomycin via microinfusion of the drug into the skin (MMP®).
de Castro Martins IM; Espósito ACC; Miot HA
An Bras Dermatol; 2024; 99(2):324-325. PubMed ID: 38071126
[No Abstract] [Full Text] [Related]
7. Sex disparities in surgery for extramammary Paget disease: a SEER population-based study.
Riva HR; Malick H; Lauck KC; Singh V; Tolkachjov SN
Int J Dermatol; 2024 Jun; ():. PubMed ID: 38867439
[No Abstract] [Full Text] [Related]
8. Assessment of HER2 status in extramammary Paget disease and its implication for disitamab vedotin, a novel humanized anti-HER2 antibody-drug conjugate therapy.
Jia J; Mao L; Lin J; Li W; Yuan P; Guo L; Dai J; Li C; Bai X; Li Z; Chen Y; Guo J; Ying J; Si L
Front Med; 2024 May; ():. PubMed ID: 38743132
[No Abstract] [Full Text] [Related]
9. A rare case of metastatic extramammary Paget disease developing transfusion-related acute lung injury during chemotherapy.
Kurokami Y; Yamashita C; Yokoi K; Tonomura K; Ishitsuka Y; Yoshida T; Koyama Y; Fujino Y; Fujimoto M; Tanemura A
J Dermatol; 2024 Apr; ():. PubMed ID: 38605433
[No Abstract] [Full Text] [Related]
10. Potent drug delivery enhancement of betulinic acid and NVX-207 into equine skin in vitro - a comparison between a novel oxygen flow-assisted transdermal application device and microemulsion gels.
Zscherpe P; Kalbitz J; Weber LA; Paschke R; Mäder K; von Rechenberg B; Cavalleri JV; Meißner J; Klein K
BMC Vet Res; 2024 May; 20(1):202. PubMed ID: 38755639
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, quality of life, and safety of methotrexate versus interferon in head-to-head treatment in advanced stages of mycosis fungoides and Sezary syndrome. Prospective trial (NCT02323659).
Chmielowska E; Sokołowska-Wojdyło M; Olszewska B; Studziński M; Grzanka-Gadzińska A; Zabłotna M; Olek-Hrab K; Iwanowski T; Olejniczak M; Krause A; Giebel S
Postepy Dermatol Alergol; 2021 Apr; 38(2):295-301. PubMed ID: 36751548
[TBL] [Abstract][Full Text] [Related]
12. Effect of an Oxygen-Based Mechanical Drug Delivery System on Percutaneous Permeation of Various Substances In Vitro.
Elksnat AL; Zscherpe P; Klein K; Cavalleri JM; Meißner J
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559216
[TBL] [Abstract][Full Text] [Related]
13. Topical treatments for early-stage mycosis fungoides using Grading Recommendations Assessment, Development and Evaluation (GRADE) criteria: A systematic review.
Wennberg E; Richards PQ; Bain PA; Huang V; Sullivan SD; Maverakis EM; Molina GE; Wu PA
JAAD Int; 2021 Jun; 3():26-41. PubMed ID: 34409369
[TBL] [Abstract][Full Text] [Related]
14. Exploratory Assessment of Oxygen Flow-Assisted Cutaneous Administration of Methotrexate for Superficial Basal Cell Carcinoma, Mycosis Fungoides, and Extramammary Paget Disease.
Lebas E; Chapelier C; Quatresooz P; Seidel L; Nikkels AF
J Invest Dermatol; 2020 Mar; 140(3):583-592. PubMed ID: 31513804
[TBL] [Abstract][Full Text] [Related]
15. Transformation in mycosis fungoides: the role of methotrexate.
Abd-el-Baki J; Demierre MF; Li N; Foss FM
J Cutan Med Surg; 2002; 6(2):109-16. PubMed ID: 11992182
[TBL] [Abstract][Full Text] [Related]
16. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
[TBL] [Abstract][Full Text] [Related]
17. Durable remission of folliculotropic mycosis fungoides achieved with a combined topical treatment with cytarabine and carmustine.
Heisig M; Maj J; Szepietowski JC; Reich A
Dermatol Ther; 2016; 29(1):15-8. PubMed ID: 26278921
[TBL] [Abstract][Full Text] [Related]
18. Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.
Cohen PR; Schulze KE; Tschen JA; Hetherington GW; Nelson BR
South Med J; 2006 Apr; 99(4):396-402. PubMed ID: 16634252
[TBL] [Abstract][Full Text] [Related]
19. [Papular mycosis fungoides].
Brajon D; Bonnet N; Dales JP; Berbis P
Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
